These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 7767538)

  • 1. Cytokine immunoreactivity in seasonal rhinitis: regulation by a topical corticosteroid.
    Bradding P; Feather IH; Wilson S; Holgate ST; Howarth PH
    Am J Respir Crit Care Med; 1995 Jun; 151(6):1900-6. PubMed ID: 7767538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-13 mRNA and immunoreactivity in allergen-induced rhinitis: comparison with IL-4 expression and modulation by topical glucocorticoid therapy.
    Ghaffar O; Laberge S; Jacobson MR; Lowhagen O; Rak S; Durham SR; Hamid Q
    Am J Respir Cell Mol Biol; 1997 Jul; 17(1):17-24. PubMed ID: 9224205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluticasone propionate aqueous nasal spray reduces inflammatory cells in unchallenged allergic nasal mucosa: effects of single allergen challenge.
    Holm A; Dijkstra M; Kleinjan A; Severijnen LA; Boks S; Mulder P; Fokkens W
    J Allergy Clin Immunol; 2001 Apr; 107(4):627-33. PubMed ID: 11295650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical glucocorticosteroid (fluticasone propionate) inhibits cells expressing cytokine mRNA for interleukin-4 in the nasal mucosa in allergen-induced rhinitis.
    Masuyama K; Jacobson MR; Rak S; Meng Q; Sudderick RM; Kay AB; Lowhagen O; Hamid Q; Durham SR
    Immunology; 1994 Jun; 82(2):192-9. PubMed ID: 7927488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nasal eosinophilia and IL-5 mRNA expression in seasonal allergic rhinitis induced by natural allergen exposure: effect of topical corticosteroids.
    Masuyama K; Till SJ; Jacobson MR; Kamil A; Cameron L; Juliusson S; Lowhagen O; Kay AB; Hamid QA; Durham SR
    J Allergy Clin Immunol; 1998 Oct; 102(4 Pt 1):610-7. PubMed ID: 9802369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical corticosteroid inhibits interleukin-4, -5 and -13 in nasal secretions following allergen challenge.
    Erin EM; Zacharasiewicz AS; Nicholson GC; Tan AJ; Higgins LA; Williams TJ; Murdoch RD; Durham SR; Barnes PJ; Hansel TT
    Clin Exp Allergy; 2005 Dec; 35(12):1608-14. PubMed ID: 16393327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of topical corticosteroids on seasonal increases in epithelial eosinophils and mast cells in allergic rhinitis: a comparison of nasal brush and biopsy methods.
    Jacobson MR; Juliusson S; Löwhagen O; Balder B; Kay AB; Durham SR
    Clin Exp Allergy; 1999 Oct; 29(10):1347-55. PubMed ID: 10520055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of IL-4, Cepsilon RNA, and Iepsilon RNA in the nasal mucosa of patients with seasonal rhinitis: effect of topical corticosteroids.
    Cameron LA; Durham SR; Jacobson MR; Masuyama K; Juliusson S; Gould HJ; Lowhagen O; Minshall EM; Hamid QA
    J Allergy Clin Immunol; 1998 Mar; 101(3):330-6. PubMed ID: 9525448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of prolonged treatment with topical corticosteroid (fluticasone propionate) on early and late phase nasal responses and cellular infiltration in the nasal mucosa after allergen challenge.
    Rak S; Jacobson MR; Sudderick RM; Masuyama K; Juliusson S; Kay AB; Hamid Q; Löwhagen O; Durham SR
    Clin Exp Allergy; 1994 Oct; 24(10):930-9. PubMed ID: 7842362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intranasal fluticasone propionate inhibits recovery of chemokines and other cytokines in nasal secretions in allergen-induced rhinitis.
    Weido AJ; Reece LM; Alam R; Cook CK; Sim TC
    Ann Allergy Asthma Immunol; 1996 Nov; 77(5):407-15. PubMed ID: 8933780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunolocalization of cytokines in the nasal mucosa of normal and perennial rhinitic subjects. The mast cell as a source of IL-4, IL-5, and IL-6 in human allergic mucosal inflammation.
    Bradding P; Feather IH; Wilson S; Bardin PG; Heusser CH; Holgate ST; Howarth PH
    J Immunol; 1993 Oct; 151(7):3853-65. PubMed ID: 8376806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo expression of signal transducer and activator of transcription factor 6 (STAT6) in nasal mucosa from atopic allergic rhinitis: effect of topical corticosteroids.
    Ghaffar O; Christodoulopoulos P; Lamkhioued B; Wright E; Ihaku D; Nakamura Y; Frenkiel S; Hamid Q
    Clin Exp Allergy; 2000 Jan; 30(1):86-93. PubMed ID: 10606935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Once daily intranasal fluticasone propionate (200 micrograms) reduces nasal symptoms and inflammation but also attenuates the increase in bronchial responsiveness during the pollen season in allergic rhinitis.
    Foresi A; Pelucchi A; Gherson G; Mastropasqua B; Chiapparino A; Testi R
    J Allergy Clin Immunol; 1996 Aug; 98(2):274-82. PubMed ID: 8757203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of seasonal allergen exposure on mucosal IL-16 and CD4+ cells in patients with allergic rhinitis.
    Pullerits T; Lindén A; Malmhäll C; Lötvall J
    Allergy; 2001 Sep; 56(9):871-7. PubMed ID: 11551252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preventive treatment of intranasal fluticasone propionate reduces cytokine mRNA expressing cells before and during a single nasal allergen provocation.
    Kleinjan A; Holm AF; Dijkstra MD; Boks SS; Severijnen L; Mulder PG; Fokkens WJ
    Clin Exp Allergy; 2000 Oct; 30(10):1476-85. PubMed ID: 10998026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of topical glucocorticoid treatment of hay fever: IL-5 and eosinophil activation during natural allergen exposure are suppressed, but IL-4, IL-6, and IgE antibody production are unaffected.
    Kita H; Jorgensen RK; Reed CE; Dunnette SL; Swanson MC; Bartemes KR; Squillace D; Blomgren J; Bachman K; Gleich GJ
    J Allergy Clin Immunol; 2000 Sep; 106(3):521-9. PubMed ID: 10984373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nasal cytology in patients with allergic rhinitis: effects of intranasal fluticasone propionate.
    Meltzer EO; Orgel HA; Rogenes PR; Field EA
    J Allergy Clin Immunol; 1994 Oct; 94(4):708-15. PubMed ID: 7930304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-9 and c-Kit+ mast cells in allergic rhinitis during seasonal allergen exposure: effect of immunotherapy.
    Nouri-Aria KT; Pilette C; Jacobson MR; Watanabe H; Durham SR
    J Allergy Clin Immunol; 2005 Jul; 116(1):73-9. PubMed ID: 15990777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intranasal beclomethasone reduces allergen-induced symptoms and superficial mucosal eosinophilia without affecting submucosal inflammation.
    Baroody FM; Rouadi P; Driscoll PV; Bochner BS; Naclerio RM
    Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):899-906. PubMed ID: 9517609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recruitment of CD1a+ Langerhans cells to the nasal mucosa in seasonal allergic rhinitis and effects of topical corticosteroid therapy.
    Till SJ; Jacobson MR; O'Brien F; Durham SR; KleinJan A; Fokkens WJ; Juliusson S; Löwhagen O
    Allergy; 2001 Feb; 56(2):126-31. PubMed ID: 11167372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.